VERSARTIS INC.

275 Shoreline Dr Ste 450, Redwood City, California, United States

Clinical Trials

2 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

36.4%

Phase 2

36.4%

Phase 3

27.3%

Trial Status Distribution

Active, not recruiting

9.1%

Completed

45.5%

Not yet recruiting

9.1%

Terminated

36.4%

Clinical Trials

Trials sponsored by this organization (11)

A Long-Term Safety Study of Somavaratan in Japanese Children With Growth Hormone Deficiency

Phase 3

Terminated

interventional

Mar 201721 participants

Open-label Extension Study to Evaluate the Safety of Long-term Twice-monthly Administration of Somavaratan in Adult Growth Hormone Deficiency (AGHD)

Phase 2

Terminated

interventional

Feb 201636 participants

Long-Acting Growth Hormone in Children Compared to Daily rhGH

Phase 3

Completed

interventional

Aug 2015138 participants

A Long Acting Growth Hormone (Somavaratan) clinical study in adults to determine effective dose.

Phase 1

Active, not recruiting

Aug 201540 participants

Versartis Trial in Pre-pubertal Japanese Children With Growth Hormone Deficiency (GHD) to Assess Long-Acting Growth Hormone (Somavaratan, VRS-317)

Phase 2

Terminated

interventional

Aug 201541 participants

Page 1 of 2

Approvals

No approval data available

News

No news articles found

Back to Organizations

VERSARTIS INC.

Overview

Trial Phase Distribution

Trial Status Distribution

Clinical Trials

Trials sponsored by this organization (11)

A Long-Term Safety Study of Somavaratan in Japanese Children With Growth Hormone Deficiency

Open-label Extension Study to Evaluate the Safety of Long-term Twice-monthly Administration of Somavaratan in Adult Growth Hormone Deficiency (AGHD)

Long-Acting Growth Hormone in Children Compared to Daily rhGH

A Long Acting Growth Hormone (Somavaratan) clinical study in adults to determine effective dose.

Versartis Trial in Pre-pubertal Japanese Children With Growth Hormone Deficiency (GHD) to Assess Long-Acting Growth Hormone (Somavaratan, VRS-317)

Versartis International Trial in Adults With Long-Acting Growth Hormone

Versartis Long-Term Safety Study of Somavaratan

Versartis Trial in Children to Assess Long-Acting Growth Hormone

Approvals

News